Patent Quality Initiative

Patcepta Kick-Off Call - January 26

Patcepta is a new open source rules engine for improving patent prosecution and management through automation. As the first of its kind, Patcepta’s goal is to provide an open, understandable, and auditable ruleset and toolkit for enabling more efficient and innovative processes and tools for managing IP portfolios.

Patcepta is hosted by Unified Patents and The Linux Foundation. Any interested party can join to help foster a new generation of IP management practices using open source software. The rules and code are open source which allows for worldwide collaboration and builds trust and confidence in those who use it.

Patcepta will hold a Kick-Off Call on January 26, 2023 at 1:30PM PST.

Invitation Details and Link Below:

Patcepta Kick Off Meeting Thursday, January 26 · 1:30 – 2:30pm

Improving Patent Quality by Changing the USPTO’s RCE and Continuation Practices

The U.S. patent system affects the work of every company and individual in the country, but can be highly technical and difficult to understand. Unified Patents is proud to celebrate Patent Quality Week - June 6-10, 2022 with a few blog posts on why patents matter and educate others about the effects of low-quality patents that can create barriers to innovation and competition.

By: Sean Keller

Background

            On January 3, 2006, the United States Patent and Trademark Office (“USPTO”) published two new rules in the Federal Register to reduce the number of continuation applications and narrow the scope of patent examinations. The new rules would have required second or subsequent continuation applications to “be supported by a showing as to why the amendment, argument, or evidence presented could not have been previously submitted.” [1] Additionally, the new rules would have required the initial examination to focus on claims the applicant designates as “representative claims.” [2] Although the proposed rules were met with overwhelmingly negative comments, the USPTO nevertheless published the Final Rules on August 21, 2007.

            GlaxoSmithKline (“GSK”), a pharmaceutical company, joined Tafas, an inventor, in suing the USPTO to prevent the proposed rules from being implemented. [3] The day before the rules were set to take effect, Judge Cacheris of the District Court for the Eastern District of Virginia granted GSK's motion for a preliminary injunction. Judge Cacheris later ruled in favor of Tafas and GSK, finding the rules exceeded the USPTO’s statutory authority. [4]

            On March 20, 2009, the Court of Appeals for the Federal Circuit affirmed in part, vacated in part, and remanded the case to the Eastern District of Virginia. [5] After the Federal Circuit decided to vacate its March 20 opinion, reinstate the appeal, and rehear the appeal en banc, the Director of the PTO signed a new Final Rule rescinding the controversial continuation rules. [6]

            Following the USPTO’s unsuccessful attempt to reduce the number of continuations and RCEs, the USPTO has declined to issue rules or make any internal changes that would change the status quo. In March 2020, 575,797 patent applications were unexamined. [7] As of March 2022, 672,514 patent applications were unexamined. [8] The number of unexamined applications will continue to increase unless the problems plaguing continuations and RCEs are addressed.

Proposed Changes

            One commentator has suggested the USPTO should replace its current task-based system that provides credits only for certain examining activities with an hours-based system that allocates credit for all examining activities. [9] Under the current system, patent examiners receive two credits, or counts, for each request for continued examination (“RCE”): one count for taking no action and one for a first office action on the merits. At the end of each two-week pay period, the USPTO adds up the number of disposals (two counts per disposal) the examiner received, multiplies that number by the period of time allocated to that examiner per disposal, and then divides that number by the total number of hours worked. Because most of the substantive examination research is completed during the initial prosecution, a patent examiner can obtain six to twenty-five hours of credit for about 30 minutes of work if the changes in the RCE are minor. Patent examiners, therefore, can reduce their workload and maximize the number of credits earned during each two-week pay period by encouraging applicants to file RCEs. If, however, the USPTO adopted an hours-based system that awarded credit for actions like second action non-final rejections, final rejections, restriction requirements, interviews, consideration of IDS filings, etc., examiners would not be incentivized to encourage applicants to file RCEs.

            Other commentators have suggested that the USPTO should charge a higher fee for filing RCEs and continuations, limit the number of RCEs and continuations applicants can file, or limit the time applicants have to file RCEs and continuations. The European Patent Office’s (“EPO”) divisional practice provides a framework for possible changes to the USPTO’s RCE and continuation practices. The EPO charges a much higher filing fee for divisional applications than the USPTO. EPO applicants also have 24 months from the first Examination Report or the request for restriction to file a divisional application whereas USPTO divisional applications merely need to be co-pending with the parent application. Furthermore, the number of EPO divisional applications is limited by the number of separate, identifiable inventions disclosed in an original patent application while there are no limits on the number of USPTO divisional applications. By adopting measures from the EPO’s divisional practice, the USPTO could discourage applicants from filing RCEs and continuations to delay prosecution and instead encourage applicants to file RCEs and continuations to further prosecution.


[1] Changes To Practice for Continuing Applications, Requests for Continued Examination Practice, and Applications Containing Patentably Indistinct Claims, 71 Fed. Reg. 48 (Jan. 3, 2006).

[2] Changes to Practice for the Examination of Claims in Patent Applications, 71 Fed. Reg. 61 (Jan. 3, 2006).

[3] Tafas v. Dudas, 511 F. Supp. 2d 652, 658, 86 U.S.P.Q.2d (BNA) 1548, 1552 (E.D. Va. 2007).

[4] Tafas v. Dudas, 541 F. Supp. 2d 805, 817, 86 U.S.P.Q.2d (BNA) 1623, 1632 (E.D. Va. 2008).

[5] Tafas v. Doll, 559 F.3d 1345, 1364, 90 U.S.P.Q.2d (BNA) 1129, 1143 (Fed. Cir. 2009).

[6] Press Release, U.S. Patent & Trademark Office, USPTO Rescinds Controversial Patent Regulations Package Proposed by Previous Administration (Oct. 8, 2009) (on file with author).

[7] Patents Production, Unexamined Inventory and Filings Data March 2022, U.S. Pat. & Trademark Off., https://www.uspto.gov/dashboard/patents/production-unexamined-filing.html (last visited May 10, 2022).

[8] Id.

[9] Patrick A. Doody, How to Eliminate the Backlog at the Patent Office, 37 AIPLA Q.J. 395, 399 (2009).

Revisiting the Liability Framework in Patent Infringement to Improve Patent Quality

The U.S. patent system affects the work of every company and individual in the country, but can be highly technical and difficult to understand. Unified Patents is proud to celebrate Patent Quality Week - June 6-10, 2022 with a few blog posts on why patents matter and educate others about the effects of low-quality patents that can create barriers to innovation and competition.

By: Michelle Aspen

I.               Introduction

Direct patent infringement is often considered a “strict liability” offense.[i] It doesn’t matter if a person accused of infringement intended to infringe, or even if they never heard of the patent or a patentee’s product before the accused conduct. No, the inquiry for patent infringement is black and white: if a person “makes, uses, offers to sell, or sells” something claimed by a patent, they will be liable for direct patent infringement.[ii]

Additionally, whether the patent owner suffered any harm or damages from the person’s actions is irrelevant to liability; the patent owner will at least be entitled to what is called a “reasonable royalty” from the time the patentee gives notice of the infringement to the accused infringer.[iii] The notice may occur either constructively, by marking products, or actually, through a demand letter or by filing a patent complaint.

Often, notice takes the latter form, sprung upon a defendant in the form of a lawsuit years after the defendant has invested in research and development, market testing, advertising, infrastructure, debugging, customer service, and their own patents related to a product or service. And damages awarded often depend on the accused infringer’s success, not the patentee’s actual contribution in the technology space.

One problem with this liability structure involves patents claiming priority to a nearly two-decade old parent patent through a chain of continuations, drafted with an eye towards technology as it is developed and commercialized by others.[iv] Such patents can be filed after the allegedly infringing conduct began, and the defendant will be expected to pay up or stop doing business for claims it never could have seen coming.

This framework fails to promote innovation. Instead, it encourages vague specifications and claims[v] and holding at least one child application open at the USPTO, exacerbating agency backlog so one can eventually read on someone else’s golden goose. Then, when a company does take risks in new markets and succeeds, the patent owner has wiggle room to capture the products in their next continuation patent.

This op-ed, which reflects my views and not those of Unified Patents, suggests that we must revisit the liability framework of patent law to improve patent quality.

II.             Background of Liability in Torts

“Strict” liability torts, also called “no-fault” torts, are torts where one can be held liable even without malice or aforethought, such as intent or negligence. In strict liability cases, a plaintiff need only prove that the act occurred and that the defendant was responsible for the act.

Typically, strict liability applies in cases where (1) the conduct in question involves something inherently dangerous, such as an exotic animal or explosives, or (2) the conduct in question involves a product whose defects could not be foreseen by a harmed end-user. In these cases, the idea is that to best serve public policy, society must hold liable those who are best equipped at preventing these harms from occurring in the first place.[vi] Another strict liability tort includes certain types of trespassing, where intent to enter another’s land is enough to show liability.

Patent law is unlike these torts. First, a plaintiff does not need to prove damages or harm from the infringing conduct—monetary harm is assumed if a patent is infringed, regardless of whether or not the patent holder ever developed or invested in a product or service outside of the fees for obtaining a patent.

Indeed, while some may find it convenient to draw an analogy between infringing what has been coined intellectual “property” and the trespass of real property, the damages available in patent cases are incomparable. Even where the patentee has shown no interest to use or make the patented concept, the damages available can be enormous. And regardless of the value provided by the patent, patentees have the right to block others through exclusive or non-exclusive licenses and obtain reasonable royalties from accused infringers for products the patentee might have never foreseen or in markets they never operated. In actual trespassing, damages must be based on injury in fact, such as the loss of use of the property or loss of market value, and injunctions are justified by the fact that land, unlike patents, involve a rivalrous property; that is, one’s use of a land limits the owner’s ability to use it, while one’s use of an idea does not limit a patentee’s ability to use it. But in patents, a reasonable royalty the minimum damages award the patentee is assumed to have incurred. Patentees may alternatively seek lost profits.

Second, there’s nothing inherently dangerous about selling a product that happens to be claimed by a patent. A patentee is never vicariously liable for an infringer’s defective products or exotic services. This point does not require much elaboration.

III.           Liability in Other Intangible-Rights Contexts

Patent liability is odd not only compared to other torts, but also other intellectual property fields. First, trade secret misappropriation typically has an intent element.

A finding of trademark infringement may be considered strict liability in that the knowledge or intention of an accused infringer to infringe the trademark is irrelevant to the finding of infringement. This is because, unlike patent law, the central focus of a trademark infringement claim is whether there is a likelihood of confusion, that is, the target consumers might confuse the alleged infringer’s product with the brand-holder’s products.[vii] Unlike patent law, however, trademark infringers must show use of their brand to obtain and enforce a trademark. And, again unlike patent law, an innocent trademark infringer will not be liable for monetary damages.[viii]

Copyright infringement liability is similar to the patent infringement framework, because liability does not exist simply on the basis of use, it is better described as a simple negligence tort than strict liability.[ix] For example, to prove infringement requires evidence of actual copying after having notice of an author’s work, and an accused infringer’s independent creation is an affirmative defense to copyright infringement.[x] Further, there are exceptions for fair use of a copyrighted work. No independent invention defense is available in patent law.

It cannot be that patents are so special or that damages are so much harder to prove than these other types of rights, because at no point in the patent process does a patentee need to prove that their patent actually provides value to society. The value is assumed based on another’s infringement, including infringement arising from another’s independent invention. Quite simply, this may be the only area of civil liability where both the mental state of the infringer is irrelevant to liability AND the minimum monetary liability is untethered to the harm suffered by the plaintiff.

IV.        Why Revisit Now: The Rise of Patent Litigation Finance

I am certainly not the first to question the liability framework of patent law, but this unique scheme has resulted in a concerning rise in litigation focused on patent claims. Over the last decade, patent litigation has become an opportunity for litigation funders to treat patent portfolios as speculative capital investments, where capitalization requires the weaponization of the federal court system against productive companies to extract settlements or jackpot jury verdicts.[xi] On its face, litigation funding is not inherently a bad thing. However, the type of plaintiffs often backed by litigation financers, non-practicing entities (NPE), make no products, are not vulnerable to countersuits, are motivated to file complaints based on vague chains of continuation patents described above, have the ability to confuse juries by anchoring the meaning of the claims to an accused product (since there are no patented products), have low operational costs to bring and maintain a suit compared to the companies they sue, and are often structured as shell companies purportedly secure from fee-penalties arising from bringing frivolous claims.[xii] Their game is one of volume, not merit.

Supporters of the litigation finance industry have a simple response to these concerns: stop infringing when you learn of the patent. Don’t do the bad thing, and you won’t get sued. If a potential defendant is innocent of wrongdoing, then the financing industry doesn’t have interest in coming after them. But this response is disingenuous, particularly for patent infringement, for at least two reasons.

First, it is not only dismissive, but naïve to simply advise companies and individuals to just, “stop infringing” because intent is not an element of patent infringement liability –defendants don’t need to be deliberate or willful in their infringement to be found liable. And when a business has reached the point that they are selling a product, they may have already invested millions in getting that product to a point where it is commercially viable. Meanwhile, patentees are not required to do anything to contribute value to this process but happen to own a tangentially related patent.

Second, and perhaps more importantly, this ignores the nature of litigation finance in the context of patent infringement. Litigation finance investments in patent portfolios are not about exposing infringers for the benefit of innovation; rather, these suits require about the same strategy as throwing darts at a target to see with the hope that a few score you some points, and maybe even a bullseye. This is possible because of the unique liability framework of patent law: no defense for innocent infringement, high defense costs, particularly multiple challenges, and a statutory-minimum for damages tied to the infringer’s commercial success.

As the NPE-Litigation Finance trend continues to grow, policy makers should consider a new liability framework to ensure that patents are about protecting innovation, not extorting it.

V.         Policy proposals

While this article is intended to encourage discussion on the topic of patent liability, it would be inappropriate to present a perceived flaw in our current system without also providing suggested solutions. The suggestions below are based on my experience in patent litigation, my discussions with others even more experienced on these topics, and my understanding of the policy goals of patent law.

Admittedly, my research in proposing these suggestions is not as rigorous or developed as I’d like. I invite constructive discourse on any suggestion. That being said, I’m not sure that any of the ideas below are entirely new, and while each has its pros and cons, so do the policies of our current system.

Suggestion 1: Remove liability for innocent infringers who have not behaved negligently, i.e., codify an affirmative defense for accidental infringement[xiii]

As a starting point for a prima facie case, notice-based liability may make sense. It would be difficult to prove actual knowledge of a patent or intent to infringe, and a high initial hurdle might disincentivize the investment in and disclosure of inventions.

However, a pure strict-liability framework (perhaps better called “notice-liability” for damages purposes) is not justifiable anymore, when patents can be bought, sold, and asserted as speculative commodities. Thus, there should be affirmative defense for an “innocent” infringer, that is, an infringer who took reasonable care not to infringe.

As an example, one innocent-infringer defense could be based on the infringer’s own patenting or licensing activity, such as if the accused infringer can show that (1) the accused infringer filed or received their own patents or licenses to patents directed to the accused technology, (2) the asserted patents were never cited during prosecution of the accused infringer’s patents, and (3) the petitioner had no reason to believe the asserted patent existed (e.g., no competing products were sold under the asserted patent when the allegedly infringing conduct began). This is just one example of how we could shield good-faith competition from the risk of seven-figure judgments.

Suggestion 2: If (a) the patent plaintiff has never produced a product or service covered by the claims of the patent AND (b) the accused infringer had no actual knowledge of the patent before the first sale of the accused products or services, then a damages award should be tied to the patent plaintiff’s pre-issuance investment in developing a prototype and obtaining a patent

The idea behind this suggestion is to balance the policy interests in innovation and competition by tying the damages to the patentee’s contributions to their alleged innovation and actual harm, rather than the accused infringer’s success, as the current reasonably-royalty minimum framework does.

Reasonable royalties and lost profits awards would still apply to productive patent holders to encourage innovation and competition by newer companies. This would also prevent a patentee from sitting on a million-dollar idea while the innocent infringer does all of the legwork to bring that idea to reality.

Suggestions 3(a) and (b): No liability for continuations filed after the first instance of accused conduct AND/OR patents subject to a terminal disclaimer presumed invalid after a parent patent is found invalid

These suggestions are lumped together because they address continuation abuse. A rule limiting liability for patents filed after infringement would protect otherwise innocent infringers from sleeper patents written to capture infringing conduct only after patentee had the benefit of hindsight. While this policy would not change the effective filing date of continuation patents, it would chill assertions of low-quality sleeper patents and incentivize clarity in claiming in the first iteration of a patent.

Additionally, daisy-chain continuations with similar claims as their parent patents pass through examination with comparatively little scrutiny. Examiners issue double-patenting rejections on these patents if the claimed subject matter is not much different from their parents. Applicants circumvent these rejections by filing a terminal disclaimer. A topic that deserves its own article, these child patents have little public value; if patentees want different claims, they have the option of filing a re-issue application on the parent patent. Continuation chains exacerbate the problem of agency backlog and frustrate emerging technologies. One way to reduce their impact would be to presume that a patent subject to a terminal disclaimer is invalid after its parent is proven invalid.

Suggestion 4: Remove liability for “use” of inventions

Removing use-based liability would (1) protect end-user consumers, including small businesses, as these entities are rarely in a position to know whether products they use infringe a patent or how to defend against a lawsuit, (2) encourage improvements or design-arounds to existing technologies by allowing competitors to experiment with them, and (3) motivate patentees to focus their patenting efforts on products or services that are more than just tangential to their business operations.

Suggestion 5: Codify a laches defense

The current statute of limitations for patent infringement is six years, not from the first act of infringement, but after any act of infringement. The long statute of limitations might be justified by the time it takes to obtain a patent, as a patent may be filed before and issued after infringement for reasons outside an inventor’s control.

But the case may arise where an accused infringer sells a product for six years either quite publicly or with the patentee’s knowledge, and then is only accused of infringement seven years later. Sometimes, the accusation may be triggered by sales of a next-generation model that uses the same accused technology as previous products but is more commercially successful for reasons unrelated to the asserted patent. In cases like this, accused infringers should be able to rely on the lack of previous accusations when innovating other aspects of their product. In the past, defendants were able to assert an equitable defense called laches to prevent claims like this, but in 2017, the Supreme Court observed that Congress never codified a laches defense.[xiv]

Not yet suggested: Reducing the patent term

One thing I have not suggested is reducing the default patent term. Because others have suggested this, it seemed appropriate to address why I have not. While a term adjustment may make sense for fast-changing and low-innovation-cost technologies, such as those in computer science, software, and novelty consumer products, it may not make sense for areas that involve research and development costs as well as hurdles imposed by other regulatory bodies before a product may come to market, such as medical technology and pharmaceutical treatments, fine-motor robotics, and large infrastructure systems like water treatment processes. The problem might not the term’s length, but the broad application of this length across all technology.

VI.        Conclusion

Promoting innovation by giving true inventors a time-limited exclusive right on their inventions is sound policy contemplated by the Constitution. But allowing innocent entrepreneurs and businesses to take risks on new products is at least as important a public interest. Given the changing patent litigation landscape, it may be time for policy-makers to revisit the liability framework in patent law to ensure that the public’s interest in promoting innovation is realized and to ensure that it doesn’t come at the price of the public’s interests in the judicial enforcement of only valid and valuable patents, appreciating those innovations, and competition.


[i] Hilton Davis Chemical Co. v. Warner-Jenkinson Co., Inc., 62 F.3d 1512, 1527 (Fed. Cir. 1995); but see Roger D. Blair and Thomas F. Cotter, Strict Liability and its Alternatives in Patent Law, 17, Berkeley Tech. L.J. 799, 800-01 (2002) (describing patent law as strict-liability in part).

[ii] 35 U.S. 271(a).

[iii] Lubby Holdings LLC v. Chung, 11 F. 4th 1355, 1360 (Fed. Cir. 2021)

[iv] According to one periodical published in 2013, non-practicing that are more likely to assert these “late-term” patents. See, e.g. Brian J. Love, An Empirical Study of Patent Litigation Timing: Could a Patent Term Reduction Decimate Trolls Without Harming Innovators, 161 Univ. Pa. L. Rev., 1312 (2013).

[v] The issue of inventors not understanding their own claims is a topic for another week.

[vi] See, e.g., Greenman v. Yuba Power Products, Inc., 377 P.2d 897 (Cal. 1963).

[vii] 15 U.S. Code § 1114(1). A simple explanation for the elements of a basic trademark infringement claim is also available at https://www.law.cornell.edu/wex/trademark_infringement.

[viii] 15 U.S. Code § 1114(2)(A).

[ix] Patrick R. Goold, Is Copyright Infringement a Strict Liability Tort, Berkeley Tech. L.J., 305, 310-11 (2015).

[x] Calhoun v. Lillenas Publishing, 298 F. 3d 1228, 1229, 1233 (11th Cir. 2002).

[xi] See, e.g., Jonathan Stroud, Pulling Back the Curtain on Complex Funding of Patent Assertion Entities, 12 Landslide, American Bar Association (2019) (describing the relationship between Fortress Investments Group and Uniloc in bringing nearly six hundred suits over six years); Dan Packel, BigLaw’s Share of the Litigation Funding Pie SkyRocketed in 2021, American Lawyer (Mar. 23, 2022) available at https://www.law.com/americanlawyer/2022/03/23/big-laws-share-of-the-litigation-funding-pie-skyrocketed-in-2021/?slreturn=20220503012320 (stating that patent litigation comprised over a quarter of all commitments from active litigation funders, an increase in 61% from the previous year); Rose Acoraci Zeck, Analysis: Why Patent Litigation is a Natural Fit for Financing, Bloomberg Law (Jan. 14, 2022) (citing an increase in the number of lawyers obtaining and financers providing funding for patent cases), available at https://news.bloomberglaw.com/bloomberg-law-analysis/analysis-why-patent-litigation-is-a-natural-fit-for-financing (links accessed June 3, 2022)

[xii] In addition to the demand on judicial and infrastructure resources, the effect of business-based patent litigation has tax revenue implications. Parties may be able to deduct legal fees and judgments or settlements associated with infringement actions. Mylan v. Commissioner, 156 T.C. No. 10 (April 27, 2021); see also Internal Revenue Service No. 201536006, available at https://www.irs.gov/pub/irs-wd/201536006.pdf.

[xiii] The idea of providing a limited defense for inadvertent or accidental infringement is not new. See Patrick R. Goold, Patent Accidents: Questioning Strict Liability in Patent Law, 95:4, Indiana L.J., 1075 (2020). Dr. Goold’s article provides a deep analysis for revisiting the strict-liability framework and introduces a potential negligence standard.

[xiv] SCA Hygiene Prods. AB v. First Quality Baby Prods. LLC, 137 S.Ct. 954, 957 (2017).

Webinar Materials - Truly Inventive: Improving the Quality of Issued Patents

Speakers:

Jonathan Stroud — Chief IP Counsel, Unified Patents

Joe Matal Partner in Intellectual Department, Haynes and Boone, LLP

In our latest webinar, Unified's Chief IP Counsel, Jonathan Stroud, was joined by Joseph Matal, Partner at Haynes and Boone, LLP, to discuss reform proposals for improving the quality of issued U.S. patents.

To listen to the recorded webinar, click here: https://vimeo.com/580879697

The slide presentation from this webinar can be seen below.

Our next webinar, Fintiv Denials in Light of ITC Cases, is scheduled for Thursday, August 26th. Visit our website for topic details and more information.

DOJ's 2015 Business Review Letter for IEEE and 2020 Supplemental Response

By: John Pierce — Legal Intern, Unified Patents

Standard Essential Patents (SEP’s) consist of patents covering technologies that are unavoidable (thus “essential”) in the implementation of new technologies under a standard. Said differently, an SEP is a fundamental piece of an advancing technology that all innovators must use to further develop the technology in accordance with a standard set by the industry. Standard Development Organizations (SDO’s) identify which pieces of an advancing technology will become a SEP. Each owner of a SEP is asked to provide assurance to license the technology under F/RAND (Fair, Reasonable, and Non-Discriminatory) terms. This assurance commits the owner to provide access to their fundamental technologies so that the advancing technology can be further innovated by other members of its tech sector. This method of standardized licensing contracting hopefully provides an increase in continuity and a decrease in patent infringement litigation.

In 2013, the Department of Justice and the U.S. Patent & Trademark Office issued a policy statement on the remedies available for SEP’s that are encumbered by a F/RAND licensing commitment. The policy statement focuses on “patent hold-up” by patent holders. Patent hold-up can occur when an owner of a technology included in a standard gains market power. This increased market power can cause delays in licensing negotiations because the patent owner can potentially gouge the licensee for a higher price because alternative technologies are difficult to implement due to the standard. In summary, this policy statement does not specifically attempt to limit or increase the remedies available to patent owners with SEP’s subject to F/RAND licensing commitments, instead, the policy statement attempts to offer guidance on what important public policy considerations govern when an injunction or exclusion order should be granted. The Department of Justice does however give examples of hypothetical situations where injunctions should or should not be given. However, The Department of Justice seems to stray from this sentiment in the future and specifically attempts to limit the remedies available to patent owners involved in SEP’s with F/RAND licensing commitments.

IEEE is an example of an SDO and the development of IEEE standards and the use of patents is overseen by the IEEE-SA Standards Board. In 2007 the IEEE-SA updated its policy in an attempt to clarify the IEEE RAND Commitment. This update gave technology owners an option to disclose their most restrictive licensing terms. In 2013, the patent committee chair of the IEEE-SA formed an ad hoc committee to address the wide discrepancy held by industry leaders in the meaning of “reasonable rates” for SEP’s as well as other important issues that had come up since the policy’s rollout. IEEE subsequently asked the Department of Justice for a Business Review Letter, analyzing their recent change in policy concerning SEP’s. The Department of Justice determined that IEEE’s changes did not warrant antitrust enforcement.  One of the important policy changes made by IEEE’s policy update was to limit prohibitive orders that could be sought from patent owners. The Department of Justice agreed that limiting prohibitive orders from patent owners could help add clarity and allow parties to reach agreement more quickly. Over the next five years, the Department’s Business Review Letter was cited and applied continually by industry members. Concurrently, the Department of Justice became more involved in pending litigations on the subject. The Department, however, did not endorse the stance it seemingly took in the 2015 Business Review Letter. Specifically, when the Department of Justice became involved in litigations from 2017-2020, it continually stood by the patent owner and did not limit the prohibitive orders that a patent owner could seek. The Department of Justice attempted to clear up this seemingly contradictory behavior in 2020 with a “Supplemental Response” on its Business Review Letter from 2015.

The 2020 response essentially vacated the stance the Department of Justice held in its 2015 Business Review Letter. This stance was consistent with the way the Department of Justice had conducted itself since the Business Review Letter. However, seven months later, the Department of Justice reclassified the Supplemental Response as “advocacy” rather than “formal guidance.” This action effectively recertifies IEEE’s Business Review Letter as good policy. The motion to re-adopt the 2015 Business Review Letter coincides with the Biden administrations tougher antitrust stance.

What does this history mean for us now?

Currently, it is not clear how exactly the current administration will handle antitrust issues with SEP’s. The way the Department of Justice has handled the 2015 Business Review Letter for IEEE is an indication of how uncertain the future is for this area of regulation. Not only substantively but also procedurally, giving many a reason to call into question the BRL process. Specifically, the 2015 BRT prohibits the holding up of the licensing process by patent owners by limiting the prohibitive orders they can receive while the 2020 supplement turned its gaze towards the holding up of the licensing process by licensees. For now, it seems the Department of Justice is taking a tougher stance on antitrust issues involving SEPs, but until there is a new exclamation of the current state of the law, the question remains: Will the Department of Justice intervene and act according to the 2020 supplement or sit on the side line and stand by the 2015 BRT? In this connection, on July 9, 2021, White House issued an executive order, asking the Attorney General and the Secretary of Commerce to “consider whether to revise their position on the intersection of the intellectual property and antitrust laws.”  July 9, 2021 Executive Order on Promoting Competition in American Economy, Section 5(d).  In particular, the executive order asked them to consider “whether to revise the Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments issued jointly by the Department of Justice, the United States Patent and Trademark Office, and the National Institute of Standards and Technology on December 19, 2019.”  Id.  Despite uncertainty, interesting developments are anticipated in this area.